SCHEMBL26097641

SCHEMBL26097641

Nc1cc(O)c(Cl)cc1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 7/20 0.60
TSHR P16473 7/20 0.60
HPGD P15428 3/20 0.60
ALDH1A1 P00352 6/20 0.54
ALOX15 P16050 4/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
ALOX12 P18054 1/20 0.54
MAPK1 P28482 1/20 0.54
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CYP3A4 P08684 6/20 0.47
TDP1 Q9NUW8 2/20 0.46
GAA P10253 2/20 0.43
CA12 O43570 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
HSP90AA1 P07900 1/20 0.42
THRB P10828 1/20 0.42
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methoxymethane SCHEMBL10956939 0.91 HSD17B10 (0.50) HSD17B10TSHRHPGDALDH1A1ALOX15
SCHEMBL29829535 0.89 HSD17B10 (0.52) HSD17B10TSHRHPGDALDH1A1ALOX15
SCHEMBL13331360 0.89 HSD17B10 (0.52) HSD17B10TSHRHPGDALDH1A1ALOX15
Hydrochloric Acid SCHEMBL16815459 0.86 ALDH1A1 (0.50) HSD17B10TSHRHPGDALDH1A1ALOX15
SCHEMBL4750720 0.86 HSD17B10 (0.56) HSD17B10TSHRHPGDALDH1A1ALOX15
SCHEMBL17000444 0.86 HSD17B10 (0.55) HSD17B10TSHRHPGDALDH1A1ALOX15
SCHEMBL18382554 0.83 GAA (0.67) HSD17B10TSHRHPGDALDH1A1ALOX15
SCHEMBL2779101 0.83 GAA (0.67) HSD17B10TSHRHPGDALDH1A1ALOX15
SCHEMBL454590 0.83 TSHR (0.60) HSD17B10TSHRHPGDALDH1A1ALOX15
SCHEMBL29408803 0.83 GAA (0.67) HSD17B10TSHRHPGDALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230139051-A1 BENZOXAZOLE DERIVATIVE AND ELECTROLUMINESCENT APPLICATION THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-04 US disclosed
US-20230139051-A1 BENZOXAZOLE DERIVATIVE AND ELECTROLUMINESCENT APPLICATION THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-04 US disclosed
US-20230139051-A1 BENZOXAZOLE DERIVATIVE AND ELECTROLUMINESCENT APPLICATION THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-04 US disclosed
CN-115043852-A Benzoxazole derivative and electroluminescent application thereof 武汉天马微电子有限公司 2022-09-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139051-A1 BENZOXAZOLE DERIVATIVE AND ELECTROLUMINESCENT APPLICATION THEREOF TSPO, XDH, TARS2 HSD17B10 2650/4885TSHR 1174/4885HPGD 2584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.